RxDoctor Payments Data

Ilina Bucur

Psychiatric/Mental Health · Everett, WANPI 1881140440

Payments from drug & device makers

$980in general payments, 2019–2025

Across 47 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$409
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$217
  • Otsuka America Pharmaceutical, Inc.$120
  • E.r. Squibb & Sons, L.L.C.$85
  • Neurocrine Biosciences, Inc.$66
  • Axsome Therapeutics, Inc.$54
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$76878%
  • Education$21222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$980 in reported general payments places this provider in the 75th percentile of 931 psychiatric/mental health providers in Washington.

See all psychiatric/mental health providers in Washington

Medicare billing

Part B allowed, 2024
$16,129
Medicare patients
38
Services billed
171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate47$165,550
Invega TrinzaPaliperidone Palmitate15$146,976
Abilify MaintenaAripiprazole35$98,886
Divalproex Sodium ErDivalproex Sodium140$10,855
Fluphenazine Hcl40$8,967
Clozapine106$7,205
Olanzapine242$5,398
Olanzapine OdtOlanzapine44$4,697
Quetiapine Fumarate144$3,154
Divalproex Sodium123$3,016
Haloperidol Decanoate34$2,739
Haloperidol81$2,434
Ziprasidone Hcl30$2,088
Oxcarbazepine56$1,859
LoxapineLoxapine Succinate51$1,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$7$312,52662 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$120$98,88635 claims
Teva Pharmaceuticals USA, Inc.Loxapine$409$1,63851 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 931 psychiatric/mental health providers in Washington.

Other psychiatric/mental health in Everett

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →